Zealand Pharma Execs to Discuss Strategy at Jefferies Healthcare Conference
Event summary
- Zealand Pharma CFO Henriette Wennicke and CSO Utpal Singh to participate in a fireside chat at the Jefferies Global Healthcare Conference on June 3, 2026.
- Live audio webcast available via Zealand Pharma's investor relations page.
- Company has two marketed products and three late-stage candidates in obesity and metabolic health.
- Collaborates with global pharma partners for research, development, and commercialization.
The big picture
Zealand Pharma's participation in the Jefferies conference underscores its focus on obesity and metabolic health, a sector experiencing rapid innovation and high investor interest. The company's AI/ML-driven R&D platform positions it as a key player, but success will depend on executing late-stage trials and leveraging partnerships effectively. With two products already marketed, the next phase will determine its long-term competitive edge.
What we're watching
- Pipeline Progress
- How Zealand Pharma's three late-stage candidates will advance in 2026 and their potential market impact.
- Partnership Dynamics
- Whether existing collaborations will accelerate commercialization timelines for obesity treatments.
- Market Positioning
- The pace at which Zealand Pharma can differentiate itself in the competitive metabolic health space.
Related topics